These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10190569)

  • 21. A novel methodology for characterizing strand-break termini and damaged bases in plasmid DNA exposed to ionizing radiation.
    Akamatsu K
    Anal Biochem; 2007 Mar; 362(2):229-35. PubMed ID: 17258165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
    Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved (32)P-postlabeling assay for the sensitive detection of 8-oxodeoxyguanosine in tissue DNA.
    Gupta RC; Arif JM
    Chem Res Toxicol; 2001 Aug; 14(8):951-7. PubMed ID: 11511168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC.
    Lau HH; Baird WM
    Carcinogenesis; 1991 May; 12(5):885-93. PubMed ID: 2029754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.
    Shigenaga MK; Gimeno CJ; Ames BN
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9697-701. PubMed ID: 2602371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of the oxidative DNA lesion, 2,2-diamino-4-(2-deoxy-beta-D-erythro-pentofuranosyl)amino]-5(2H)-oxazolone (oxazolone), in vitro and in vivo by isotope dilution-capillary HPLC-ESI-MS/MS.
    Matter B; Malejka-Giganti D; Csallany AS; Tretyakova N
    Nucleic Acids Res; 2006; 34(19):5449-60. PubMed ID: 17020926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of TLC- and HPLC-32P-postlabelling assay for cisplatin-DNA adducts.
    Försti A; Staffas J; Hemminki K
    Carcinogenesis; 1994 Dec; 15(12):2829-34. PubMed ID: 8001242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of DNA alkylphosphotriesters by 32P postlabeling: evidence for the nonrandom manifestation of phosphotriester lesions in vivo.
    Guichard Y; Jones GD; Farmer PB
    Cancer Res; 2000 Mar; 60(5):1276-82. PubMed ID: 10728687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of atherosclerosis.
    De Flora S; Izzotti A; Walsh D; Degan P; Petrilli GL; Lewtas J
    FASEB J; 1997 Oct; 11(12):1021-31. PubMed ID: 9337155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postlabelling methods for the detection of apurinic sites and radiation-induced DNA damage.
    Weinfeld M; Buchko GW
    IARC Sci Publ; 1993; (124):95-103. PubMed ID: 8225514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 32P-postlabeling assay for free radical-induced DNA damage: the formamido remnant of thymine.
    Maccubbin AE; Budzinski EE; Patrzyc H; Evans MS; Ersing N; Box HC
    Free Radic Res Commun; 1993; 18(1):17-28. PubMed ID: 8349146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection by 32P-postlabeling of thymidine glycol in gamma-irradiated DNA.
    Hegi ME; Sagelsdorff P; Lutz WK
    Carcinogenesis; 1989 Jan; 10(1):43-7. PubMed ID: 2910530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic excision of radiation-induced lesions from DNA model compounds.
    Maccubbin A; Evans M; Paul CR; Budzinski EE; Przybyszewski J; Box HC
    Radiat Res; 1991 Apr; 126(1):21-6. PubMed ID: 1850532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
    Pfau W; Brockstedt U; Söhren KD; Marquardt H
    Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine.
    Shields PG; Povey AC; Wilson VL; Weston A; Harris CC
    Cancer Res; 1990 Oct; 50(20):6580-4. PubMed ID: 2208119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
    Reddy MV
    Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.